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Abstract: The sea constitutes one of the most promising sources of novel compounds with 
potential  application  in  human  therapeutics.  In  particular,  algae  have  proved  to  be  an 
interesting  source  of  new  bioactive  compounds.  In  this  work,  six  meroditerpenoids 
(epitaondiol,  epitaondiol  diacetate,  epitaondiol  monoacetate,  stypotriol  triacetate,  
14-ketostypodiol  diacetate  and  stypodiol)  isolated  from  the  brown  alga  Stypopodium 
flabelliforme were tested for their cell proliferation inhibitory activity in five cell lines. Cell 
lines  tested  included  human  colon  adenocarcinoma  (Caco-2),  human  neuroblastoma  
(SH-SY5Y),  rat  basophilic leukemia (RBL-2H3), murine macrophages  (RAW.267)  and 
Chinese  hamster  fibroblasts  (V79).  Antimicrobial  activity  of  the  compounds  was  also 
evaluated  against  Staphylococcus  aureus,  Salmonella  typhimurium,  Proteus  mirabilis, 
Bacillus cereus, Enterococcus faecalis and Micrococcus luteus. Overall, the compounds 
showed good activity against all cell lines, with SH-SY5Y and RAW.267 being the most 
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susceptible. Antimicrobial capacity was observed for epitaondiol monoacetate, stypotriol 
triacetate and stypodiol, with the first being the most active. The results suggest that these 
molecules deserve further studies in order to evaluate their potential as therapeutic agents. 
Keywords: Stypopodium flabelliforme; meroditerpenoids; anti-proliferative; antimicrobial 
 
1. Introduction  
Nature  is  an  amazing  source  of  chemical  diversity  and,  as  a  consequence,  naturally-derived 
compounds have unique pharmacological properties. This is easily observed if we consider that nearly 
60%  of  all  drugs  introduced  in  therapy  between  1981  and  2006  were  first  identified  as  natural 
products.  This  number  rises  to  75%  if  we  only  consider  cancer  drugs  [1].  When  compared  with 
synthetic compounds, natural molecules usually have well-defined three-dimensional structures and fit 
biological targets that are conserved across species. 
Products from marine origin have been increasingly used in human health, a trend that is likely to 
grow in the future [2]. Due to the harsh conditions that challenge marine organisms, such as low 
temperatures and light availability and high pressure, among others, marine organisms respond by 
synthesizing a number of secondary metabolites, some of them with potent pharmacological properties. 
In particular, algae have been referenced for producing molecules with amazing chemical diversity 
and, consequently, have interesting effects in humans. Molecules synthesized by algae show a number 
of different bioactivities, including anticancer [2–4], antibacterial [5] and immunomodulation [6], and 
are well documented for their use in an ethnopharmacological context. 
Meroditerpenoids are a class of natural products consisting on a polyprenyl chain attached to a 
hydroquinone  ring  moiety  and  include  plastoquinones,  chromanols  and  chromenes.  This  class  of 
compounds is common in brown algae and sometimes is used for taxonomic classification [7]. Brown 
algae (Phaeophyceae) produce a great variety of secondary metabolites, possessing many different 
skeletal types and biological activities. 
Due to the increasing prevalence and incidence of cancer in both developing and developed countries, 
new molecules to be used in cancer chemotherapy are needed. In this work, six meroditerpenoids 
(epitaondiol,  epitaondiol  diacetate,  epitaondiol  monoacetate,  stypotriol  triacetate,  14-ketostypodiol 
diacetate and stypodiol) (Figure 1) isolated from the brown alga Stypopodium flabelliforme were tested 
for their anti-proliferative properties against the cancer cell lines SH-SY5Y (human neuroblastoma), 
Caco-2  (human  colorectal  adenocarcinoma),  RBL-2H3  (rat  basophilic  leukemia)  and  RAW.267 
(mouse macrophages) and towards V79 non-cancer cell line (Chinese hamster fibroblasts). Few studies 
have addressed the potential biological activities of the meroditerpenoids studied herein. Soares et al. 
described the activity of epitaondiol against herpes simplex virus [8]. Epitaondiol diacetate was studied 
for its pharmacological effects in rat cardiovascular system and a negative inotropic effect of 35% was 
observed. A negative chronotropic effect was also noticed [9]. Epitaondiol and stypotriol triacetate 
revealed marked anti-inflammatory activities via decreased secretion of eicosanoids and modulation of 
the cyclooxigenase pathway through inhibition of some key enzymes, such as phospholipase A2, as 
assayed using [
3H]oleate-labeled membranes of Escherichia coli [10].  Mar. Drugs 2011, 9  
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Figure 1. Structures of the meroditerpenoids evaluated in this study. 
Epitaondiol
Stypotriol triacetate 14-Ketostypodiol diacetate Stypodiol
Epitaondiol diacetate Epitaondiol monoacetate
 
The  antimicrobial  activity  of  these  compounds  has  already  been  verified  against  several  bacteria, 
namely  Bordetella  bronchiseptica,  Pseudomonas  aeroginosa,  Escherichia  coli,  Bacillus  subtilis, 
Bacillus pumilus, Bacillus anthracis and Staphylococcus epidermidis, and the results obtained showed 
moderate  antimicrobial  capacity  [11].  Nevertheless,  the  study  of  their  antimicrobial  capacity  was 
herein extended to other microorganisms. 
2. Results and Discussion 
2.1. Cell Proliferation Inhibition 
Sulforhodamine B (SRB) is an aminoxanthene dye bearing two sulfonic groups, with a strong pink 
color. The SRB assay for cell proliferation inhibition testing relies on the ability of this molecule to 
bind to basic amino acids residues in acidic conditions and dissociate at basic pH. This binding is 
stoichiometric and thus, the amount of dye extracted from stained cells is directly proportional to the 
cell  mass.  For  this  reason,  this  test  has  been  widely  used  for  the  evaluation  of  inhibition  of  cell 
proliferation [12].  
In the work herein, meroditerpenoids from S. flabelliforme were tested for their ability to inhibit cell 
proliferation using a panel of human (Caco-2 and SH-SY5Y) and non-human (RBL-2H3 and RAW.267) 
cancer cell lines, as well as V79 non-cancer cells. 
All  cancer  cells  were  affected  by  exposure  to  the  compounds,  although  the  several  cell  lines 
exhibited different sensitivities (Figures 2–6). Among the cell lines assayed, RAW.267 was one of the 
most affected and showed a significant inhibition of cell proliferation (Figure 2), with epitaondiol, 
epitaondiol  monoacetate  and  stypotriol  triacetate  displaying  nearly  100%  inhibition  at  all  tested 
concentrations.  Epitaondiol  diacetate,  14-ketostypodiol  diacetate  and  stypodiol  also  displayed  a 
concentration-dependant activity, although to a lesser extent (Figure 2). In fact, in general, epitaondiol, 
epitaondiol  monoacetate  and  stypotriol  triacetate  were  the  most  toxic  compounds  to  all  cell  lines 
(Figures 2–6). Mar. Drugs 2011, 9  
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Figure 2. Effects of meroditerpenoids on the inhibition of cell proliferation in RAW.267 
cells using the SRB assay. Values show mean + SE inhibition, as compared to negative 
control  (0.1%  DMSO),  from  three  experiments  performed  in  triplicate.  **  p  <  0.005;  
*** p < 0.0005. 
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SH-SY5Y, a thrice-cloned neuroblastoma, originally from SK-N-SH, was the cell line displaying 
the highest susceptibility to the meroditerpenoids (Figure 3), on a par with RAW.267. Overall, with the 
exception of epitaondiol diacetate, all compounds exhibited nearly 100% inhibition of cell proliferation 
at the highest tested dose. IC 50 of 12.2 µM and 14 µM were found for epitaondiol and stypotriol 
triacetate, respectively, which were the most active compounds (Figure 3a). The positive control used 
in this study, vincristine, yielded an IC50 of 0.03 µM. The neurotoxicity of meroditerpenoids has been 
observed before, but only 2β,3ʱ-epitaondiol, an isomer of epitaondiol, was studied using a mouse  
cell  line,  neuro2a.  With  this  mouse  cell  line,  Sabry  and  colleagues  [13]  observed  the  effect  of  
2β,3ʱ-epitaondiol and other meroditerpenoids and a LD50 between 2 and 11 μM was found [13]. To the 
best  of  our  knowledge,  this  is  the  first  time  that  the  human  neurotoxicity  of  these  compounds  is 
addressed. This cell line is particularly prone to damage caused by oxidative stress [14,15].  
For  Caco-2  cell  line  all  compounds  showed  a  concentration-dependent  inhibitory  effect,  with 
stypotriol  triacetate  being  the  most  active,  followed  by  epitaondiol  monoacetate  and  epitaondiol 
(Figure 4). A similar trend was found regarding RBL-2H3 cell line (Figure 5). 
Regardless  of  the  effect  against  cancer  cells,  cytotoxic  compounds  are  interesting  for  human 
chemotherapy only when their toxicity is higher for cancer cells than for non-cancer ones. For this 
reason we tested the ability of the meroditerpenoids to inhibit cell proliferation of the non-cancer cell 
line V79 (Figure 6). Epitaondiol diacetate, 14-ketostypodiol diacetate and stypodiol revealed to have 
little  or  no  effect  on  non-cancer  V79  cell  line,  while  against  the  cancer  cell  lines  these  same 
compounds displayed a selective activity (Figures 2–5). This selectivity against specific cancer cell 
lines is one of the requirements for the development of new drugs in order to lower the extent of  
side-effects. 14-Ketostypodiol diacetate has already proved to inhibit microtubules assembly and cell 
proliferation in DU-145 human prostatic cancer cells [16]. Mar. Drugs 2011, 9  
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Figure 3. Effects of meroditerpenoids on the inhibition of cell proliferation in SH-SY5Y 
cells using the SRB assay. (a) Most and (b) less active compounds. For the most active (a), 
it was possible to test five different concentrations. Values show mean + SE inhibition, as 
compared to negative control (0.1% DMSO), from three experiments performed in triplicate. 
* p < 0.05; *** p < 0.0005. 
(a)  SH-SY5Y
3
.
1
2
5
6
.
2
5
1
2
.
5
2
5
5
0
3
.
1
2
5
6
.
2
5
1
2
.
5
2
5
5
0 0
50
100
Epitaondiol
Stypotriol triacetate
[Compound] (M)
*** ***
* *
%
 
i
n
h
i
b
i
t
i
o
n
 
o
f
 
c
e
l
l
 
p
r
o
l
i
f
e
r
a
t
i
o
n
 
(b)  SH-SY5Y
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Figure 4. Effects of meroditerpenoids on the inhibition of cell proliferation in Caco-2 cells 
using the SRB assay. Values show mean + SE inhibition, as compared to negative control 
(0.1% DMSO), from three experiments performed in triplicate. * p < 0.05; ** p < 0.005; 
*** p < 0.0005. 
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Figure 5. Effects of meroditerpenoids on the inhibition of cell proliferation in RBL-2H3 
cells using the SRB assay. Values show mean + SE inhibition, as compared to negative 
control  (0.1%  DMSO),  from  three  experiments  performed  in  triplicate.  *  p  <  0.05;  
** p < 0.005; *** p < 0.0005. 
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Figure 6. Effects of meroditerpenoids on the inhibition of cell proliferation in V79 cells 
using the SRB assay. Values show mean + SE inhibition, as compared to negative control 
(0.1% DMSO), from three experiments performed in triplicate. ** p < 0.005; *** p < 0.0005. 
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The results obtained in the present work point to the possible use of this class of compounds in a 
context of human chemotherapy against cancer. Nevertheless, further studies are required in order to 
understand the mechanism of action of these compounds. 
2.2. Antimicrobial Activity 
Compounds  exhibiting  antimicrobial  properties  for  concentrations  lower  than  64  µg/mL  are 
accepted as having notable antimicrobial activity [17], while those showing activity at concentrations 
below 10 µg/mL are considered as “clinically significant” [17,18].  
Epitaondiol monoacetate, stypotriol triacetate and stypodiol showed some antimicrobial capacity, 
with  the  first  displaying  the  major  effect  against  gram-positive  and  gram-negative  bacteria  
(MIC  ≥  114 µg/mL) (Table 1). E.  faecalis  appeared to be the most sensitive species.  As  for the Mar. Drugs 2011, 9  
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remaining compounds, all bacteria were found to be resistant under the tested concentrations (Table 1). 
Thus, the compounds studied can hardly be considered good antimicrobial candidates. 
Table 1. MIC of S. flabelliforme meroditerpenoids against selected bacteria. 
Bacteria 
Alga compounds (µ g/mL) 
Epitaondiol 
Epitaondiol 
diacetate 
Epitaondiol 
monoacetate 
Stypotriol 
triacetate 
14-Ketostypodiol 
diacetate 
Stypodiol 
Gram-positive 
           
S. aureus  >206  >249  >114  >277  >241  >206 
M. luteus  >206  >249  >114  >277  >241  >206 
E. faecalis  >206  >249  114  277  >241  206 
B. cereus  >206  >249  >114  >277  >241  >206 
Gram-negative 
            P. mirabillis  >206  >249  >114  >277  >241  >206 
S. typhimurium  >206  >249  >114  >277  >241  >206 
3. Experimental Section  
3.1. Compounds Isolation and Characterization 
The brown alga Stypopodium flabelliforme was obtained from the underwater environment near 
Easter Island, Pacific Ocean. Isolation and characterization procedures were previously reported by  
us [19–21]. Generally, fresh algae were repeatedly extracted with dichloromethane. The extract was 
concentrated  under  reduced  pressure  and  applied  to  a  Sephadex  LH-20  column.  Because  of  the 
instability  of  the  compounds,  polar  fractions  were  immediately  acetylated  with  pyridine/acetic 
anhydride in order to avoid oxidation. Purification was done by thin layer chromatography (TLC) and 
column  chromatography  (CC)  using  grade  silica  gel.  Complete  spectroscopic  characterization, 
including 
1H  NMR, 
13C  NMR  and  UV  data  has  been  published  before  for  stypotriol  triacetate, 
epitaondiol diacetate, epitaondiol monoacetate and epitaondiol [21], as well as for 14-ketostypodiol 
diacetate [20]. Stypodiol was obtained by hydrolysis of stypodiol diacetate previously isolated by the 
team  [19].  Briefly,  stypodiol  diacetate  (30  mg)  was  refluxed  in  basic  aluminum  oxide  (1  mg)  in 
benzene  (30  mL)  for  12  h  [21].  Benzene  was  removed  under  reduced  pressure  and  the  residue 
dissolved in water (10 mL), extracted with dichloromethane (3 ×  20 mL), dried, and evaporated to 
yield a solid (20 mg). 
Stypodiol. 
1H NMR (400 MHz, CDCl3) ʴ 6.42 (1H, brs), 6.40 (1H, brs), 3.25 (1H, dd, J = 11.6, 4.8), 
3.21 (1H, d, J = 16.4), 2.75 (1H, d, J = 16.4), 2.18 (3H, s), 0.94 (6H, s), 0.86 (3H, s), 0.77 (3H, s), 
0.67 (1H, d, J = 6.3). In agreement with literature [22]. 
Peak purity of all compounds was checked by HPLC analysis, using an HPLC unit (Gilson) and a 
Spherisorb ODS2 column (4.6 ×  250 mm, 5 μm particle size). The eluent used was acetonitrile, at a 
flow rate of 0.9 mL/min. Detection was achieved with a Gilson diode array detector. Spectral data 
from all peaks were accumulated in the range of 200–400 nm, and chromatograms were recorded at 
280 nm for all compounds, excepting sytpodiol, which was determined at 305 nm. The data were 
processed on a Unipoint Software system (Gilson Medical Electronics, Villiers le Bel, France). All tested 
compounds were >99% pure, excepting 14-ketostypodiol diacetate (>95%) and stypodiol (>80%). Mar. Drugs 2011, 9  
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3.2. Reagents 
Sulforhodamine B (SRB), dimethylsulfoxide (DMSO) and vincristine were from Sigma-Aldrich 
(Steinheim,  Germany).  Dulbecco’s  Modified  Eagle  Medium  (DMEM),  fetal  bovine  serum  (FBS), 
phosphate  buffer  saline  (PBS),  human  transferrin,  fungizone  and  penicillin  were  from  GIBCO 
(Invitrogen, UK). Tris-base, acetic acid and trichloroacetic acid were from Merck (Germany). Mueller 
Hinton  Broth  (MHB)  and  Mueller  Hinton  Agar  (MHA)  media  were  purchased  from  Liofilchem 
(Teramo, Italy). The water was treated in a Milli-Q water purification system (Millipore, Bedford, MA). 
3.3. Cell Culture 
Caco-2, V79, SH-SY5Y and RAW.267 cells were a kind gift from Professor Fernando Remiã o 
from the Laboratory of Toxicology, Faculty of Pharmacy, Porto University, Portugal. RBL-2H3 cells 
were obtained from ATTC. All cells were maintained in DMEM with 10% FBS and 1% penicillin, 
excepting RBL-2H3, which were cultivated in 15% FBS. V79 and Caco-2 cells were additionally 
added non-essential amino acids and, in the case of Caco-2, human-transferrin and fungizone. All cells 
were grown in an incubator at 37 °C  and 5% CO2. 
Stock solutions of all compounds in DMSO were prepared and diluted in media for testing. Cells 
were allowed to attach for 24 h, after which they were exposed to the compounds.  
3.4. Sulforhodamine B Assay 
The method by Houghton et al. [23], with modifications [24], was followed. Cells were plated with 
a density of 2 ×  10
4 (V79, RBL-2H3, Caco-2 and RAW.267) and 1.5 ×  10
4 (SH-SY5Y) cells/well and 
allowed to attach for 24 h at 37 ° C, with 5% CO2. On the following day the medium was removed and 
cells  were  gently  washed  with warm PBS. Compounds in media were added and  the  plates  were 
incubated for 48 h. The anticancer compound vincristine was used as a positive control. 
After the incubation period media was removed, 100 µL of cold 40% trichloroacetic acid was added 
and plates were maintained at 4 °C  for 60 min. Plates were then washed 5 times with tap water and 
allowed  to  dry.  Afterwards,  50  µL  of  0.4%  SRB  in  1%  acetic  acid  were  added  and  plates  were 
incubated for 30 min. 
After the incubation period plates were quickly washed with 1% acetic acid, in order to remove 
unbound  dye,  and  allowed  to  dry.  100  µL  of  tris-base  were  added  and  after  10  min  the  plates  
were shaken. 
Absorbance at 492 nm was determined in a multi-plate reader. OD values were plotted against 
concentration. Three independent assays were conducted, each one of them in triplicate. Values of 
inhibition of cell proliferation were expressed against a control of 0.1% DMSO. 
3.5. Statistical Analysis 
Comparisons of data from different groups versus control were performed by one-way ANOVA 
test, using GraphPad Prism 5. A p value lower than 0.05 was considered statistically significant. Mar. Drugs 2011, 9  
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3.6. Antimicrobial Activity 
3.6.1. Microorganisms 
Six  bacterial  species  were  used  for  the  experiments:  Staphylococcus  aureus  (ATCC  20231), 
Salmonella typhimurium (ATCC 43971), Proteus mirabilis (ATCC 4479), Bacillus cereus (ATCC 31), 
Enterococcus faecalis (ATCC 20477) and Micrococcus luteus (ATCC 20030). Cultures were obtained 
from the Laboratory of Microbiology, Faculty of Pharmacy, Porto University, Portugal. Stock cultures 
were maintained on MHA at 4 °C . Bacterial inocula were prepared by growing cells in MHB for  
24  h,  at  37  °C .  Cell  suspensions  were  diluted  in  sterile  MHB  to  provide  initial  cell  counts  of  
about 10
6 CFU/mL. 
3.6.2. Antibacterial Effect 
The minimum inhibitory concentrations (MIC) of the compounds studied herein were determined 
by two-fold serial dilution method, in 96-well plates. The compounds were dissolved in 5% (v/v) 
DMSO/MHB to a final concentration of 500 µM, excepting epitaondiol monoacetate, for which it was 
250  µM  due  to  solubility  issues.  Dilution  series  were  prepared  to  obtain  concentration  ranges  of  
31.3–500 µM. 95 µL of MHB and 5 µL of suspension inoculum with 10
6 CFU/mL were added in each 
well, which contained 100 µL of each compound’s solution. The negative control well consisted on 
195 µL of MBH alone with 5% DMSO (v/v) and 5 µL of the standard inocula [25]. The plates were 
agitated using a plate shaker and incubated at 37 °C , for 24 h. The MIC of the tested compounds was 
detected following addition (40 µL) of 0.2 mg/mL p-iodonitrotetrazolium chloride and incubation at 
37 °C  for 30 min [26]. Viable microorganisms reduced the yellow dye to pink color. 
MIC was defined as the lowest sample concentration that prevented dye’s change and exhibited 
complete inhibition of bacterial growth. The experiments were performed in duplicate and repeated 
independently three times. 
4. Conclusions 
In this work we evaluated the anti-proliferative ability of meroditerpenoids isolated from the brown 
alga S. flabelliforme against several cancer and non-cancer cell lines. All tested compounds inhibited 
the proliferation of cancer cells, but their activity against the non-cancer cell line was less marked. 
The  SH-SY5Y  human  neuroblastoma  cell  line  showed  higher  susceptibility  towards  these 
meroditerpenoids than all of the other cell lines, thus pointing to the neurotoxicity of these secondary 
metabolites. Further studies are required in order to understand the mechanisms of action of these 
molecules and their potential application in cancer chemotherapy. 
Low  antimicrobial  capacity  was  observed  for  epitaondiol  monoacetate,  stypotriol  triacetate  and 
stypodiol, with the first being the most active. Mar. Drugs 2011, 9  
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